BRC Therapeutics
- Biotech or pharma, therapeutic R&D
BRC Therapeutics (BRC) is a pharmaceutical company focused on developing proprietary cannabinoid therapeutics to address unmet medical needs. BRC’s medicines are multimodal and contain major and minor cannabinoids at defined ratios. BRC has developed a pipeline of treatments addressing pain and neurological and inflammatory conditions. Two investigational products are currently being tested in patient clinical trials for Complex Regional Pain Syndrome (CRPS) and Aromatase Inhibitor-Induced Arthralgia (AIIA), respectively. BRC is registered with the Drug Enforcement Administration.
Address
CastrovilleCalifornia
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}